Table 4.
Individualsa with prevalent malformation syndromes associated with microcephaly in Rivne Province (2000–2009)
| Categorya | Polissia | Non-Polissia | Rivne Province | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ratea | All | Sex | Rate | All | Sex | Rate | All | Sex | ||||
| M | F | M | F | M | F | |||||||
| FASDb | 5.1 | 37 | 19 | 18 | 5.7 | 42 | 25 | 17 | 5.4 | 79 | 44 | 35 |
| Included in alternative categories | 1.4 | 10 | 7 | 3 | 1.5 | 11 | 6 | 5 | 1.4 | 21 | 13 | 8 |
| among Microcephaly | 1.2 | 9 | 7 | 2 | 1.5 | 11 | 6 | 5 | 1.4 | 20 | 13 | 7 |
| PATAU SYNDROME/TRISOMY 13 | n/c | 9 | 5 | 4 | n/c | 11 | 8 | 2 | n/c | 20 | 13 | 6 |
| Included in alternative categories | n/c | 8 | 5 | 3 | n/c | 9 | 6 | 2 | n/c | 17 | 11 | 5 |
| Holoprosencephaly | n/c | 5 | 3 | 2 | n/c | 6 | 4 | 1 | n/c | 11 | 7 | 3 |
| Microphthalmia | n/c | 2 | 1 | 1 | n/c | 1 | 1 | n/c | 3 | 2 | 1 | |
| Omphalocele | n/c | 1 | 1 | n/c | 1 | 1 | n/c | 2 | 1 | 1 | ||
| Microcephaly | n/c | 1 | 1 | n/c | 1 | 1 | ||||||
| HOLOPROSENCEPHALYc | n/c | 13 | 8 | 5 | n/c | 23 | 12 | 7 | n/c | 36 | 20 | 12 |
| Associations | ||||||||||||
| and Microcephalyd | n/c | 2 | 2 | n/c | 1 | 1 | n/c | 3 | 3 | |||
| and Microphthalmiae | n/c | 3 | 2 | 1 | n/c | 2 | 1 | 1 | n/c | 5 | 3 | 2 |
| and Teratomaf | n/c | 1 | 1 | n/c | 1 | 1 | ||||||
In contrast to Table 2 and its derivatives where individuals are only represented once, in this table the rate is calculated as total impacted individuals who may be represented in several malformation categories (shown in capital letters). Individuals represented in sub-categories are mutually exclusive. Also note an alternative presentation of similar data in Table 5 and clinical summaries of all individuals contained in the Data Supplement. M indicates males and F indicates females.
FASD, Fetal Alcohol Spectrum Disorders.
Includes Patau syndrome (see above).
Includes one individual (hol-6) with holoprosencephaly-microcephaly-microphthalmos association.
Excludes above individual (hol-6).
Included one individual with cervico-faringeal teratoblastoma (neo-1).
n/c, not computed.